A Short Progressive Supranuclear Palsy Quality of Life Scale

Author:

Jensen Ida12ORCID,Stiel Stephanie3,Bebermeier Sarah4,Schrag Anette5ORCID,Greten Stephan1ORCID,Doll‐Lee Johanna1ORCID,Wegner Florian1,Ye Lan1,Heine Johanne1,Krey Lea1,Höllerhage Matthias1,Süß Patrick67,Winkler Jürgen67,Berg Daniela8,Paschen Steffen8,Tönges Lars910ORCID,Gruber Doreen1112,Gandor Florin1112ORCID,Jost Wolfgang H.13ORCID,Kühn Andrea A.1415,Claus Inga16,Warnecke Tobias17,Pedrosa David J.18,Eggers Carsten19,Trenkwalder Claudia20,Classen Joseph21,Schwarz Johannes22,Pötter‐Nerger Monika23ORCID,Kassubek Jan2425ORCID,Schnitzler Alfons26,Höglinger Günter U.227,Klietz Martin1ORCID

Affiliation:

1. Department of Neurology Hannover Medical School Hannover Germany

2. Department of Neurology LMU University Hospital Munich Germany

3. Institute for General Practice and Palliative Care, Hannover Medical School Hannover Germany

4. Department of Pedagogic Psychology Leibniz University Hannover Hannover Germany

5. Department of Clinical and Movement Neurosciences Queen Square Institute of Neurology London United Kingdom

6. Department of Molecular Neurology, University Hospital Erlangen Friedrich‐Alexander‐Universität Erlangen‐Nürnberg Erlangen Germany

7. Center of Rare Diseases Erlangen (ZSEER), University Hospital Erlangen Friedrich‐Alexander‐Universität Erlangen‐Nürnberg Erlangen Germany

8. Department of Neurology Kiel University Kiel Germany

9. Department of Neurology, St. Josef‐Hospital Ruhr University Bochum Bochum Germany

10. Neurodegeneration Research, Protein Research Unit Ruhr (PURE) Ruhr University Bochum Bochum Germany

11. Movement Disorders Hospital, Beelitz‐Heilstätten Beelitz‐Heilstätten Germany

12. Department of Neurology Otto‐von‐Guericke University Magdeburg Magdeburg Germany

13. Parkinson‐Klinik Ortenau Wolfach Germany

14. Movement Disorder and Neuromodulation Unit, Department of Neurology, Charité University Medicine Berlin Berlin Germany

15. German Center for Neurodegenerative Diseases (DZNE) Berlin Germany

16. Department of Neurology with Institute of Translational Neurology University Hospital Muenster Muenster Germany

17. Department of Neurology and Neurorehabilitation Klinikum Osnabrueck—Academic teaching hospital of the WWU Muenster Osnabrueck Germany

18. Department of Neurology University Hospital of Marburg Marburg Germany

19. Department of Neurology Knappschaftskrankenhaus Bottrop Bottrop Germany

20. Paracelsus‐Elena Klinik Kassel Germany

21. Department of Neurology University of Leipzig Medical Center Leipzig Germany

22. Department of Neurology Klinik Haag I. OB Mühldorf a. Inn Germany

23. Department of Neurology University Medical Center Hamburg‐Eppendorf Hamburg Germany

24. Department of Neurology University of Ulm Ulm Germany

25. German Center for Neurodegenerative Diseases (DZNE), Oberer Eselsberg Ulm Germany

26. Institute of Clinical Neuroscience and Medical Psychology, and Department of Neurology University of Düsseldorf Düsseldorf Germany

27. Munich Cluster for Systems Neurology (SyNergy) Munich Munich Germany

Abstract

AbstractObjectiveThe Progressive Supranuclear Palsy quality of life scale (PSP‐QoL) has been shown to be a useful tool for capturing health‐related quality of life of patients in “everyday life” and in progressive supranuclear palsy (PSP) research. However, at 45 items in length, the questionnaire can take a long time, exhausting PSP patients, in particular if cognitive impaired, which can have a negative impact on the assessment. The aim of this study was to establish a condensed version of the PSP‐QoL for research and routine clinical care.MethodsIn this retrospective study, data originating from a German cohort of PSP patients was analyzed. Data from 245 PSP patients were included in this study. The short PSP‐QoL questionnaire was created using a two‐factor solution and item‐total and inter‐item correlations for mental and physical aspects of daily living of the PSP‐QoL followed by confirmatory factor analysis.ResultsThe final scale included 12 items representing mental (five items) and physical symptoms (seven items). The specified two‐factor model displayed an excellent fit in the confirmatory factor analysis. The short Progressive Supranuclear Palsy Quality of Life scale (PSP‐ShoQoL) correlated moderately with the PSP Rating Scale (r [243] = 0.514, P < 0.001) and Geriatric depression scale (r [231] = 0.548, P < 0.001). Sensitivity to change confirmed a significant decrease in QoL after 12 months.DiscussionIn this study, we created a 12‐item PSP‐ShoQoL designed to “facilitate” daily clinical work that correlated strongly with the PSP‐QoL and was sensitive to change. © 2024 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.

Publisher

Wiley

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3